KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Treasury Shares (2016 - 2025)

Biogen (BIIB) has 17 years of Treasury Shares data on record, last reported at $3.0 billion in Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.0% year-over-year to $3.0 billion; the TTM value through Dec 2025 reached $3.0 billion, changed 0.0%, while the annual FY2025 figure was $3.0 billion, 0.0% changed from the prior year.
  • Treasury Shares reached $23.8 million in Q4 2025 per BIIB's latest filing, up from -$23.8 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $23.8 million in Q4 2021 and bottomed at -$23.8 million in Q1 2022.
  • Average Treasury Shares over 5 years is -$3.4 million, with a median of $1.2 million recorded in 2022.
  • The widest YoY moves for Treasury Shares: up 0.0% in 2021, down 0.0% in 2021.
  • A 5-year view of Treasury Shares shows it stood at $3.0 billion in 2021, then changed by 0.0% to $3.0 billion in 2022, then changed by 0.0% to $3.0 billion in 2023, then changed by 0.0% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $3.0 billion in Q4 2025, $3.0 billion in Q3 2025, and $3.0 billion in Q2 2025.